Evidence map›Paper›PMID 35105810›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients.

Jami R Erickson, Terry Stevens-Ayers, Florian Mair, Bradley Edmison, Michael Boeckh, Philip Bradley, Martin Prlic

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jami R EricksonVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.ORCID 0000-0002-4549-5217
Terry Stevens-AyersVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Florian MairVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.ORCID 0000-0001-6732-5449
Bradley EdmisonVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Michael BoeckhVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.ORCID 0000-0003-1538-7984
Philip BradleyPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 pbradley@fredhutch.org mprlic@fredhutch.org.ORCID 0000-0002-0224-6464
Martin PrlicVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; pbradley@fredhutch.org mprlic@fredhutch.org.
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHCR01AI136514 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Paul G. Thomas · 2018 to 2026
$6.9M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host ImmunityR01AI123323 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRLIC, MARTIN · 2017 to 2025
$5.0M
Molecular modeling and machine learning for protein structures and interactionsR35GM141457 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2021 to 2025
$2.1M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
NIAID NIH HHS R01 AI123323NIAID NIH HHS R01 AI136514NIAID NIH HHS T32 AI007509NIGMS NIH HHS R35 GM141457NIH HHS S10 OD028685
6 · The paper itself

Abstract

Competition between antigen-specific T cells for peptide:MHC complexes shapes the ensuing T cell response. Mouse model studies provided compelling evidence that competition is a highly effective mechanism controlling the activation of naïve T cells. However, assessing the effect of T cell competition in the context of a human infection requires defined pathogen kinetics and trackable naïve and memory T cell populations of defined specificity. A unique cohort of nonmyeloablative hematopoietic stem cell transplant patients allowed us to assess T cell competition in response to cytomegalovirus (CMV) reactivation, which was documented with detailed virology data. In our cohort, hematopoietic stem cell transplant donors and recipients were CMV seronegative and positive, respectively, thus providing genetically distinct memory and naïve T cell populations. We used single-cell transcriptomics to track donor versus recipient-derived T cell clones over the course of 90 d. We found that donor-derived T cell clones proliferated and expanded substantially following CMV reactivation. However, for immunodominant CMV epitopes, recipient-derived memory T cells remained the overall dominant population. This dominance was maintained despite more robust clonal expansion of donor-derived T cells in response to CMV reactivation. Interestingly, the donor-derived T cells that were recruited into these immunodominant memory populations shared strikingly similar TCR properties with the recipient-derived memory T cells. This selective recruitment of identical and nearly identical clones from the naïve into the immunodominant memory T cell pool suggests that competition is in place but does not interfere with rejuvenating a memory T cell population. Instead, it results in selection of convergent clones to the memory T cell pool.

Indexed as

Hematopoietic Stem Cell TransplantationTissue DonorsAdultAgedAged, 80 and overCD8-Positive T-LymphocytesCytomegalovirusCytomegalovirus InfectionsFemaleHumansMaleMemory T CellsMiddle AgedVirus ActivationCD8 T cellCMV reactivationhuman transplantT cell competition

Identifiers

PMID35105810
PMCPMC8833188
OpenAlexW4220828120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.